Federal officials say they have identified and can fix the biggest flaws in their online insurance marketplace after an inaugural week marked by system outages and long wait times.
Federal officials say they have identified and can fix the biggest flaws in their online insurance marketplace after an inaugural week marked by system outages and long wait times.
In response to a flood of visitors to its healthcare.gov site, HHS said it continues to beef up server capacity while updating software to make the site better able to accommodate large numbers of users. Healthcare.gov is the enrollment conduit for 36 states that declined to operate their own exchanges under the Patient Protection and Affordable Care Act.
HHS also said a major software component became “overstressed,” preventing many consumers from accessing the site and signing up for accounts. That component has since been moved to dedicated hardware from “virtual machine technology,” a move that has eased the bottleneck, HHS said.
Read the full story here: http://bit.ly/19pufp6
Source: Modern Healthcare
Black Youths Overlabeled High Risk in Mental Health Emergencies
May 9th 2025Despite similar scores on an aggression risk evaluation tool in a pediatric emergency department, Black youths were significantly more likely to be labeled with a high aggression risk behavioral health flag in their electronic health records compared with White youths.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen